Previous Article | Next Article 
Applied and Environmental Microbiology, December 2007, p. 7753-7756, Vol. 73, No. 23
0099-2240/07/$08.00+0 doi:10.1128/AEM.01228-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Detection of Salmonella enterica Subpopulations by Phenotype Microarray Antibiotic Resistance Patterns
,
Jean Guard-Bouldin,1*
Cesar A. Morales,1
Jonathan G. Frye,2
Richard K. Gast,1 and
Michael Musgrove1
U.S. Department of Agriculture, ESQRU,1
U.S. Department of Agriculture, BEAR, 950 College Station Road, Athens, Georgia 306052
Received 1 June 2007/
Accepted 26 September 2007

ABSTRACT
Three strains of
Salmonella enterica serotype Enteritidis were
compared to
Salmonella enterica serotype Heidelberg,
Salmonella enterica serotype Newport, and
Salmonella enterica serovar Typhimurium
for growth in the presence of 240 antibiotics arranged within
a commercial high-throughput phenotype microarray. The results
show that antibiotic resistances were different for subpopulations
of serotype Enteritidis separated only by genetic drift.

INTRODUCTION
Salmonella enterica serotype Enteritidis is the only one of
over 1,400
Salmonella enterica serotypes that efficiently contaminates
the contents of eggs and causes disease in humans (
4,
15,
20).
It is a model serotype for evaluating how genetic drift impacts
phenotype, because mutational mapping of genetically related
pathotypes has been completed. Current estimates of the genetic
distances between serotype Enteritidis subpopulations, between
serotype Enteritidis phage types, and between serotype Enteritidis
and other
Salmonella serotypes with a common lipopolysaccharide
core structure are estimated at one single-nucleotide polymorphism
for every 10,000, 1,000, and 100 contiguous base pairs, respectively.
A rapid screening method that detects the subpopulation biology
of strains that appear to be clonal would facilitate epidemiological
investigations that monitor the emergence of genetic drift that
impacts human health. To identify antibiotics for this purpose,
we used a commercially available high-throughput phenotype microarray
(Phenotype MicroArray [PM]; Biolog, Inc.) to compare the antibiotic
resistance patterns of three subpopulations of serotype Enteritidis
to those of three other serotypes of
S. enterica, namely serotype
Heidelberg, serovar Typhimurium, and serotype Newport. Specifically,
the strains evaluated were (i) egg-contaminating, biofilm-positive
serotype Enteritidis phage type 4 strain ESQRU 22079 (serotype
Enteritidis PT4) (
17); (ii) biofilm-positive serotype Enteritidis
phage type 13a strain ESQRU 21027, which does not contaminate
eggs (BF serotype Enteritidis PT13a) (
18); (iii) wild-type egg-contaminating
serotype Enteritidis PT13a strain ESQRU 21046, which does not
produce biofilm (wt serotype Enteritidis PT13a) (
18); (iv) serotype
Heidelberg strain ESQRU 23018, a human isolate from a rare egg-associated
outbreak (
13); (v) serotype Newport strain ESQRU 24012, which
has multiple antibiotic resistances; and (vi) serovar Typhimurium
strain ESQRU 99187, which was isolated from the environment
of chickens. Strains of these four serotypes were recovered
from 50%, 53%, and 51% of laboratory-confirmed cases of salmonellosis
in the United States for the years 2004, 2005, and 2006, respectively
(
26).

PM analysis.
PM testing was performed by Biolog's PM Services group (Hayward,
CA). The basic growth medium chemistry for PM analysis was published
previously (
3,
27). PM analysis was conducted in duplicate after
incubation of the strains at 37°C for 48 h, and the data
were analyzed by Student's
t test to confirm that the results
were uniform between runs. The metabolism of
D-serine was an
internal control, because BF serotype Enteritidis PT13a has
a 10-bp deletion in the serine deaminase gene (
dsdA), and the
algorithm for defining when wells were otherwise positive for
growth above baseline based on the respiratory activity (RA)
of the cells in the initial inoculum has been described previously
(
18). Raw data were obtained for 10 96-well master plates (Biolog
PM plates 11 to 20), which included 240 antibiotics arranged
as a dilution series across four wells (960 wells in total).
Data were recorded as RAs and were filtered in Microsoft Excel
to identify statistically significant differences by Student's
t test (see Table S1 in the supplemental material). Antibiotic
susceptibilities were also tested by a conventional assay (Sensititre
Microbiologic Systems, Westlake, OH) (
12).

Results.
The conventional assay indicated that serotype Newport had multiple
antibiotic resistances and that wt serotype Enteritidis PT13a
was resistant to ampicillin and tetracycline (Table
1). Filtering
of all PM data indicated that the results for five ß-lactam
antibiotics and sodium selenite showed significant (
P < 0.001)
differences between BF and wt serotype Enteritidis PT13a (Table
2). Wild-type serotype Enteritidis PT13a grew almost as well
as serotype Newport in the ß-lactam antibiotics amoxicillin,
carbenicillin, and penicillin G in the PM (Table
2): specifically,
serotype Newport had average RAs of 329.6, 296.0, and 345.6,
and wt serotype Enteritidis PT13a had average RAs of 270.4,
274.3, and 289.8 for these compounds, respectively (see Table
S1 in the supplemental material) (
18). Both wt serotype Enteritidis
PT13a and serotype Newport grew in sodium selenite (RA >
50), whereas BF serotype Enteritidis PT13a did not (Table S1
in the supplemental material). Overall, sensitivity to the ß-lactam
antibiotics differentiated between monomorphic strains of serotype
Enteritidis as well as did the control compound
D-serine, which
links an easily observable phenotype to a known genomic lesion—a
10-bp deletion (bp 3880104 to 3880113 within the reference genome
of serotype Enteritidis PT4). Two other findings for the compounds
in Table
2 were that the monomorphic BF serotype Enteritidis
PT13a strains were significantly different from all other strains
and that wt serotype Enteritidis PT13a had resistances that
were more similar to those of serotype Newport than could be
detected by the conventional assay (Table
2). The sensitivity
of wt serotype Enteritidis PT13a to amoxicillin-clavulanic acid
in the conventional assay is more appropriately reported as
intermediate, because values were eight times higher than those
for any of the other
Salmonella strains that were sensitive
(Table
1).
View this table:
[in this window]
[in a new window]
|
TABLE 2. Differentiation of S. enterica subpopulations and serotypes by antibiotic compounds that differentiate between monomorphic subpopulations of serotype Enteritidis
|
Thirty-six compounds distinguished monomorphic PT13a strains
from dimorphic serotype Enteritidis PT4 and from all other serotypes
(Table
3). Serovar Typhimurium was somewhat unique, because
its sensitivity was intermediate to that of monomorphic and
dimorphic strains of serotype Enteritidis (Table
3). Serovar
Typhimurium grew more like monomorphic serotype Enteritidis
PT13a strains in 14 (38.9%) of the 36 compounds, whereas serotype
Heidelberg and serotype Newport resembled monomorphic strains
in their growth in only 8.3% and 11.1% of the compounds, respectively.
These results suggest that serotype Heidelberg and serotype
Newport grew more like dimorphic serotype Enteritidis PT4 than
like the monomorphic strains.
View this table:
[in this window]
[in a new window]
|
TABLE 3. Differentiation of S. enterica subpopulations and serotypes by antibiotic compounds that screen for dimorphism
|
The conventional assay for antibiotic resistances suggested
that wt serotype Enteritidis PT13a was resistant to tetracycline.
However, there was no evidence of this resistance in the PM
(Table
4). In contrast, serotype Newport was resistant to tetracycline
antibiotics (
P < 0.01) in both the conventional and PM assays.
The resistance of wt serotype Enteritidis PT13a to tetracycline
thus appears to be overstated by the conventional assay. Differences
in antibiotic concentrations and in the media used to assess
resistance could account for the variation between assays.
View this table:
[in this window]
[in a new window]
|
TABLE 4. Differentiation of S. enterica subpopulations and serotypes by the tetracycline class of antibiotic compounds
|

Conclusions.
Several recent antibiogram studies of field isolates suggest
that serotype Enteritidis is developing some antibiotic resistances
(
2,
5-
11,
14,
16,
19,
21-
25). However, genomic resequencing
has not detected any differences in the
mar regulon of strains
of serotype Enteritidis. If the chromosome of serotype Enteritidis
bacteria is currently evolving antibiotic resistances from small-scale
evolutionary events, then an assay for subpopulation biology
using antibiotics could help identify genetic drift that impacts
public health (
1). The results from these analyses improved
the interpretation of resistances to the ß-lactam
and tetracycline classes of antibiotics by combining information
from both the PM and conventional assays. Overall, resistance
to ß-lactam antibiotics was understated and resistance
to the tetracycline class was overstated for serotype Enteritidis
by the conventional assay.

Microarray data sequence.
The sequence data for serotype Enteritidis PT4 were produced
by the Pathogen Genome Sequencing Group at the Sanger Institute
and can be obtained from
ftp://ftp.sanger.ac.uk/pub/pathogens/Salmonella/SePT4.dbs.
Complete mutational maps and partial confirmatory comparative
genome resequencing data for BF and wt serotype Enteritidis
PT13a are available at
http://www.ncbi.nlm.nih.gov/genomes/static/Salmonella_SNPS.html.

ACKNOWLEDGMENTS
This research was supported primarily by funds from ARS project
number 6612-32000-004-00. Funds for the analysis of conventional
resistance were provided by ARS project number 6612-32000-002-00.

FOOTNOTES
* Corresponding author. Mailing address: U.S. Department of Agriculture, Agricultural Research Service, Egg Safety and Quality Research Unit, 950 College Station Road, Athens, GA 30605. Phone: (706) 546-3446. Fax: (706) 546-3035. E-mail:
Jean.Guard.Bouldin{at}ars.usda.gov 
Published ahead of print on 26 October 2007. 
Supplemental material for this article may be found at http://aem.asm.org/. 

REFERENCES
1 - Baquero, F. 2001. Low-level antibacterial resistance: a gateway to clinical resistance. Drug Resist. Updat. 4:93-105.[CrossRef][Medline]
2 - Batchelor, M., K. Hopkins, E. J. Threlfall, F. A. Clifton-Hadley, A. D. Stallwood, R. H. Davies, and E. Liebana. 2005. blaCTX-M genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003. Antimicrob. Agents Chemother. 49:1319-1322.[Abstract/Free Full Text]
3 - Bochner, B. R., P. Gadzinski, and E. Panomitros. 2001. Phenotype microarrays for high-throughput phenotypic testing and assay of gene function. Genome Res. 11:1246-1255.[Abstract/Free Full Text]
4 - Brenner, F. W., R. G. Villar, F. J. Angulo, R. Tauxe, and B. Swaminathan. 2000. Salmonella nomenclature. J. Clin. Microbiol. 38:2465-2467.[Free Full Text]
5 - Cardinale, E., J. D. Perrier Gros-Claude, K. Rivoal, V. Rose, F. Tall, G. C. Mead, and G. Salvat. 2005. Epidemiological analysis of Salmonella enterica ssp. enterica serovars Hadar, Brancaster and Enteritidis from humans and broiler chickens in Senegal using pulsed-field gel electrophoresis and antibiotic susceptibility. J. Appl. Microbiol. 99:968-977.[CrossRef][Medline]
6 - Carraminana, J. J., C. Rota, I. Agustin, and A. Herrera. 2004. High prevalence of multiple resistance to antibiotics in Salmonella serovars isolated from a poultry slaughterhouse in Spain. Vet. Microbiol. 104:133-139.[CrossRef][Medline]
7 - Chiappini, E., L. Galli, P. Pecile, A. Vierucci, and M. de Martino. 2002. Results of a 5-year prospective surveillance study of antibiotic resistance among Salmonella enterica isolates and ceftriaxone therapy among children hospitalized for acute diarrhea. Clin. Ther. 24:1585-1594.[CrossRef][Medline]
8 - Choi, S. H., J. H. Woo, J. E. Lee, S. J. Park, E. J. Choo, Y. G. Kwak, M. N. Kim, M. S. Choi, N. Y. Lee, B. K. Lee, N. J. Kim, J. Y. Jeong, J. Ryu, and Y. S. Kim. 2005. Increasing incidence of quinolone resistance in human nontyphoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance. J. Antimicrob. Chemother. 56:1111-1114.[Abstract/Free Full Text]
9 - Chung, Y. H., S. Y. Kim, and Y. H. Chang. 2003. Prevalence and antibiotic susceptibility of Salmonella isolated from foods in Korea from 1993 to 2001. J. Food Prot. 66:1154-1157.[Medline]
10 - de Oliveira, F. A., A. Brandelli, and E. C. Tondo. 2006. Antimicrobial resistance in Salmonella enteritidis from foods involved in human salmonellosis outbreaks in southern Brazil. New Microbiol. 29:49-54.[Medline]
11 - Dias de Oliveira, S., F. Siqueira Flores, L. R. dos Santos, and A. Brandelli. 2005. Antimicrobial resistance in Salmonella enteritidis strains isolated from broiler carcasses, food, human and poultry-related samples. Int. J. Food Microbiol. 97:297-305.[CrossRef][Medline]
12 - Frye, J. G., and P. J. Fedorka-Cray. 2007. Prevalence, distribution and characterisation of ceftiofur resistance in Salmonella enterica isolated from animals in the USA from 1999 to 2003. Int. J. Antimicrob. Agents 30:134-142.[CrossRef][Medline]
13 - Gast, R. K., J. Guard-Bouldin, and P. S. Holt. 2004. Colonization of reproductive organs and internal contamination of eggs after experimental infection of laying hens with Salmonella heidelberg and Salmonella enteritidis. Avian Dis. 48:863-869.[CrossRef][Medline]
14 - Hradecka, H., I. Kolackova, R. Karpiskova, and I. Rychlik. 2006. An outbreak of human salmonellosis caused by ampicillin-resistant Salmonella enterica serovar Enteritidis PT13 in the Czech Republic. Epidemiol. Infect. 134:737-740.[CrossRef][Medline]
15 - Humphrey, T. J., A. Baskerville, S. Mawer, B. Rowe, and S. Hopper. 1989. Salmonella enteritidis phage type 4 from the contents of intact eggs: a study involving naturally infected hens. Epidemiol. Infect. 103:415-423.[Medline]
16 - Kariuki, S., G. Revathi, N. Kariuki, J. Muyodi, J. Mwituria, A. Munyalo, D. Kagendo, L. Murungi, and C. A. Hart. 2005. Increasing prevalence of multidrug-resistant nontyphoidal salmonellae, Kenya, 1994-2003. Int. J. Antimicrob. Agents 25:38-43.[CrossRef][Medline]
17 - Kinde, H., D. H. Read, R. P. Chin, A. A. Bickford, R. L. Walker, A. Ardans, R. E. Breitmeyer, D. Willoughby, H. E. Little, D. Kerr, and I. A. Gardner. 1996. Salmonella enteritidis, phase type 4 infection in a commercial layer flock in southern California: bacteriologic and epidemiologic findings. Avian Dis. 40:665-671.[CrossRef][Medline]
18 - Morales, C. A., S. Porwollik, J. G. Frye, H. Kinde, M. McClelland, and J. Guard-Bouldin. 2005. Correlation of phenotype with the genotype of egg-contaminating Salmonella enterica serovar Enteritidis. Appl. Environ. Microbiol. 71:4388-4399.[Abstract/Free Full Text]
19 - Rodriguez-Avial, I., C. Rodriguez-Avial, O. Lopez, and J. J. Picazo. 2005. Trends in nalidixic acid resistance in nontyphoidal Salmonella isolated from 1999 to 2002: decreased susceptibility to 6 fluoroquinolones. Diagn. Microbiol. Infect. Dis. 52:261-264.[CrossRef][Medline]
20 - St. Louis, M. E., D. L. Morse, M. E. Potter, T. M. DeMelfi, J. J. Guzewich, R. V. Tauxe, and P. A. Blake. 1988. The emergence of grade A eggs as a major source of Salmonella enteritidis infections. New implications for the control of salmonellosis. JAMA 259:2103-2107.
21 - Suh, D. K., and J. C. Song. 2006. Analysis of Salmonella enterica serotype Enteritidis isolated from human and chickens by repetitive sequence-PCR fingerprinting, antibiotic resistance and plasmid profiles. J. Vet. Sci. 7:37-41.[Medline]
22 - Threlfall, E. J., M. Day, E. de Pinna, A. Charlett, and K. L. Goodyear. 2006. Assessment of factors contributing to changes in the incidence of antimicrobial drug resistance in Salmonella enterica serotypes Enteritidis and Typhimurium from humans in England and Wales in 2000, 2002 and 2004. Int. J. Antimicrob. Agents 28:389-395.[CrossRef][Medline]
23 - Tzouvelekis, L. S., V. Lukova, P. T. Tassios, A. C. Fluit, R. N. Jones, and N. J. Legakis. 2003. Resistance to beta-lactams among blood isolates of Salmonella spp. in European hospitals: results from the SENTRY Antimicrobial Surveillance Program 1997-98. Clin. Microbiol. Infect. 9:149-152.[CrossRef][Medline]
24 - Velge, P., A. Cloeckaert, and P. Barrow. 2005. Emergence of Salmonella epidemics: the problems related to Salmonella enterica serotype Enteritidis and multiple antibiotic resistance in other major serotypes. Vet. Res. 36:267-288.[CrossRef][Medline]
25 - Velonakis, E. N., A. Markogiannakis, L. Kondili, E. Varjioti, Z. Mahera, E. Dedouli, A. Karaitianou, N. Vakalis, and K. Bethimouti. 2001. Evolution of antibiotic resistance of nontyphoidal salmonellae in Greece during 1990-97. Euro Surveill. 6:117-120.[Medline]
26 - Vugia, D., A. Cronquist, J. Hadler, M. Tobin-D'Angelo, D. Blythe, K. Smith, S. Lathrop, D. Morse, P. Cieslak, T. Jones, K. G. Holt, J. J. Guzewich, O. L. Henao, E. Scallan, F. J. Angulo, P. M. Griffin, R. V. Tauxe, and S. K. Greene. 2007. Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food—10 states, 2006. Morb. Mortal. Wkly. Rep. 56:336-339.[Medline]
27 - Zhou, L., X.-H. Lei, B. R. Bochner, and B. L. Wanner. 2003. Phenotype microarray analysis of Escherichia coli K-12 mutants with deletions of all two-component systems. J. Bacteriol. 185:4956-4972.[Abstract/Free Full Text]
Applied and Environmental Microbiology, December 2007, p. 7753-7756, Vol. 73, No. 23
0099-2240/07/$08.00+0 doi:10.1128/AEM.01228-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Biondi, E. G., Tatti, E., Comparini, D., Giuntini, E., Mocali, S., Giovannetti, L., Bazzicalupo, M., Mengoni, A., Viti, C.
(2009). Metabolic Capacity of Sinorhizobium (Ensifer) meliloti Strains as Determined by Phenotype MicroArray Analysis. Appl. Environ. Microbiol.
75: 5396-5404
[Abstract]
[Full Text]